SPHERA FUNDS MANAGEMENT LTD. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 84 filers reported holding CTI BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2018$4,355,000
+34.0%
874,407
+4.9%
0.60%
+21.5%
Q1 2018$3,251,000
+45.5%
833,6330.0%0.49%
+88.5%
Q4 2017$2,234,000
-16.0%
833,6330.0%0.26%
-30.9%
Q3 2017$2,659,000–833,633–0.38%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2018.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders